A novel adenosine 2A receptor antagonist HZ-086 enhances the efficiency of immunotherapy and alleviates the acquired resistance to PD-L1 by restoration of T cell functions
DOI:
10.1016/j.ejphar.2025.177535
Publication Date:
2025-03-20T01:27:20Z
AUTHORS (13)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....